EP2367542
Form af bendamústín til inngjafar í gegnum munn
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.12.2009EP published:
1.1.2014EP application number:
09796303.7
EP translation filed:
27.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
2.12.2029Expiry date:
2.12.2023
Title:
ORAL DOSAGE FORMS OF BENDAMUSTINE
Timeline
Today
3.12.2009EP application
1.1.2014EP Publication
27.2.2014Translation submitted
15.3.2014Registration published
2.12.2023Expires
Owner
Name:
PHARMA& SCHWEIZ GMBHAddress:
Riedstrasse 1, 6330 Cham, CH
Inventor
Name:
COLLEDGE, JeffreyAddress:
AH Leiden, NL
Name:
OLTHOFF, MargarethaAddress:
AH Leiden, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08075915Date:
3.12.2008Country:
EP
Classification
Categories:
A61K 9/48, A61K 9/14, A61K 31/4184
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 11.11.2014
Expires: 2.12.2015
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 18.11.2015
Expires: 2.12.2016
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 18.11.2016
Expires: 2.12.2017
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.11.2017
Expires: 2.12.2018
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.11.2018
Expires: 2.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 19.11.2019
Expires: 2.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.11.2020
Expires: 2.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 18.11.2021
Expires: 2.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 13.12.2022
Expires: 2.12.2023
Payer: G.H. Sigurgeirsson ehf.